Everest Biotech/7α, 25-dihydroxycholesterol 1mg/2300070012/1mg,Everest Biotech,,Everest Biotech,everestbiotech,+,,Array.Array.Array蚂蚁淘厂家直采.

产品名称：Everest Biotech/7α, 25-dihydroxycholesterol 1mg/2300070012/1mg

产品编号：2300070012

市场价：¥1029.60

场地：美国(厂家直采)

产品分类：生化试剂>缓冲液>酸碱缓冲液>

联系QQ：1570468124

电话号码：4000-520-616

邮箱： info@ebiomall.com

美元价：$99.00

品牌： Everest Biotech

公司：Everest Biotech

公司分类：

商品介绍

Synonyms	cholest-5-ene-3β,7α,25-triol
MolecularFormula:	C₂₇H₄₆O₃
MolecularWeight:	418.684g/mol
ExactMass:	418.345g
PercentComposition:	C77.46%H11.07%O11.46%
Purity:	>99%
StABIlity:	6months
Storage:	-20°C

Hannedoucheetal.(2011)OxysterolsdirectimmunecellmigrationviaEBI2.Nature475:524–527.[Abstract]

MATERIALSAFETYDATASHEET

TRADENAME:7-alpha,25-dihydroxycholesterol

DATEOFISSUE:Oct24,2013

SKU#:2300070012(1mg),2300070052(5mg),2300070102(10mg),2300020013(1g),2300020023(2g),2300020033(3g)

SECTIONI:PRODUCTANDMANUFACTURERINFORMATION

TRADENAME:7α,25-dihydroxycholesterol

Supplier:EtonBioscienceInc.,5820OberlinDrive,Suite108,SanDiego,CA92121

InformationTelephone:800.758.1630

EmergencyTelephone:800.758.1630

SECTIONII:COMPOSITION/INFORMATIONONINGREDIENTS

ChemicalName;7α,25-dihydroxycholesterol

Synonyms:7α,25-dihydroxycholesterol

Hazardousingredients:

MolecularWeight:418.652g/mol

CASNumber:64907-22-8

SECTIONIII:HAZARDIDENTIFICATION

EmergencyOverview

OSHAHazards
NoknownOSHAhazards
HMISClassification
HealthHazard:0
Flammability:0
Physicalhazards:0

NFPARating
HealthHazard:0
Fire:0
ReactivityHazard:0

PotentialHealthEffects
InhalationMaybeharmfulifinhaled.Maycauserespiratorytractirritation.
SkinMaybeharmfulifabsorbedthroughskin.Maycauseskinirritation.
EyesMaycauseeyeirritation.
IngestionMaybeharmfulifswallowed

SECTIONIV:FIRSTAIDMEASURES

Incaseofeyecontact:Checkforandremoveanycontactlenses.Flusheyeimmediatelywithrunningwaterforatleast15minutes.Callaphysician.

Incaseofskincontact:washwithplentyofwater.Gentlyandthoroughlywashthecontaminatedskinwithrunningwater.

Incaseofinhalation:Removetofreshair.Ifnotbreathinggiveartificialrespiration

Incaseofingestion:Nevergiveanythingbymouthtoanunconsciousperson.Rinsemouthwithwater.

SECTIONV:FIREFIGHTINGMEASURES

Flammableproperties:Flashpointnodataavailable.Ignitiontemperaturenodataavailable

Suitableextinguishingmedia:Usewaterspray,alcohol-resistantfoam,drychemicalorcarbondioxide.

Specialprotectiveequipmentforfire-fighters:Wearselfcontainedbreathingapparatusforfirefightingifnecessary.

SECTIONVI:ACCIDENTALRELEASEMEASURES

Personalprecautions:Avoiddustformation.

Environmentalprecaution:Donotletproductenterdrains.

Methodsforcleaningup:Sweepupandshovel.Keepinsuitable,closedcontainersfordisposal.

SECTIONVII:HANDLINGANDSTORAGE

Handling:Provideappropriateexhaustventilationatplaceswheredustisformed.Normalmeasuresforpreventivefireprotection.

Storage:Keepcontainertightlyclosedinadryandwell-ventilatedplace.Recommendedstoragetemperature:-20°C

SECTIONVIII:EXPOSURECONTROLS/PERSONALPROTECTION

Containsnosubstanceswithoccupationalexposurelimitvalues.

SECTIONIX:PHYSICALANDCHEMICALPROPERTIES

Appearance:Formpowder,lyophilized

Molecularformula:C₂₇H₄₆O₃

MolecularWeight:418.652g/mol

pH:nodataavailable
Meltingpoint:nodataavailable
Boilingpoint:nodataavailable
Flashpoint:nodataavailable
Ignitiontemperature:nodataavailable
Lowerexplosionlimit:nodataavailable
Upperexplosionlimit;nodataavailable
Watersolubility:nodataavailable

SECTIONX:STABILITYANDREACTIVITY

Storagestability:Stableunderrecommendedstorageconditions.
Materialstoavoid:Strongoxidizingagents
Hazardousdecompositionproducts:Hazardousdecompositionproductsformedunderfireconditions.-Carbonoxides

SECTIONXI:TOXICOLOGICALINFORMATION

Acutetoxicity:nodataavailable
Irritationandcorrosion:nodataavailable
Sensitisation:nodataavailable

Chronicexposure
IARC:Nocomponentofthisproductpresentatlevelsgreaterthanorequalto0.1%isidentifiedasprobable,possIBLeorconfirmedhumancarcinogenbyIARC.

ACGIH:Nocomponentofthisproductpresentatlevelsgreaterthanorequalto0.1%isidentifiedas
acarcinogenorpotentialcarcinogenbyACGIH.

NTP:Nocomponentofthisproductpresentatlevelsgreaterthanorequalto0.1%isidentifiedas
aknownoranticipatedcarcinogenbyNTP.

OSHA:Nocomponentofthisproductpresentatlevelsgreaterthanorequalto0.1%isidentifiedas
acarcinogenorpotentialcarcinogenbyOSHA.

PotentialHealthEffects
Inhalation:Maybeharmfulifinhaled.Maycauserespiratorytractirritation.
Skin:Maybeharmfulifabsorbedthroughskin.Maycauseskinirritation.
Eyes:Maycauseeyeirritation.
Ingestion:Maybeharmfulifswallowed.

SECTIONXII:ECOLOGICALINFORMATION

Eliminationinformation(persistenceanddegradability):nodataavailable
Ecotoxicityeffects:nodataavailable
Furtherinformationonecology:nodataavailable

SECTIONXIII:DISPOSALCONSIDERATIONS

Product:Observeallfederal,state,andlocalenvironmentalregulations.
Contaminatedpackaging:Disposeofasunusedproduct.

SECTIONXIV:TRANSPORTINFORMATION

DOT:NotDangerousgoods
IMDG:NotDangerousgoods
IATAclass:NotDangerousgoods

SECTIONXV:REGULATORYINFORMATION

OSHAHazards:NoknownOSHAhazards
TSCAStatus:NotOnTSCAInventory.CasNumber:64907-22-8
DSLStatus:ThisproductcontainsthefollowingcomponentsthatarenotontheCanADIanDSLnorNDSLlists.CasNumber:64907-22-8
SARA302Components:NochemicalsinthismaterialaresubjecttothereportingrequirementsofSARATitleIII,Section302.
SARA313Components:ThismaterialdoesnotcontainanychemicalcomponentswithknownCASnumbersthatexceedthethreshold(DeMinimis)reportinglevels
establishedbySARATitleIII,Section313.
SARA311/312Hazards:NoSARAHazards
MassachusettsRightToKnowComponents:NoComponentsListed
PennsylvaniaRightToKnowComponents:7α,25-dihydroxycholesterolCasNumber:64907-22-8
NewJerseyRightToKnowComponents:7α,25-dihydroxycholesterolCasNumber:64907-22-8
CaliforniaProp.65Components:ThisproductdoesnotcontainanychemicalsknowntoStateofCaliforniatocausecancer,birth,oranyotherreproductivedefects.

SECTIONXVI:OTHERINFORMATION

Theinformationaboveisbelievedtobeaccurateandrepresentsthebestinformationcurrentlyavailabletous.However,wemakenowarrantyofmerchantabilityoranyotherwarranty,expressorimplied,withrespecttosuchinformation.Usersshouldmaketheirowninvestigationstodeterminethesuitabilityoftheinformationfortheirparticularpurposes.EtonBioscienceInc.shallnotbeheldliableforanydamagesorotherconsequencesresultingfromhandlingorfromcontactwiththeaboveproduct.

ENDOFDATASHEET

品牌介绍

Everest Biotech公司成立于2000年，由英国牛津大学一批生物化学家创建。公司科学家团队具有丰富的抗体纯化及蛋白组学专业知识，雄厚的专业背景赋予了公司能为全球科研人员提供高质量、创新性抗体产品的能力。目前，Everest Biotech可提供3000余种抗体，涉及肿瘤、自身免疫、过敏、心血管疾病、传染病、代谢、神经科学等领域。所有抗体均由Everest Biotech自主研发生产、全部经过肽亲和纯化以保证最佳的特异性和纯度、经过免疫原肽的ELISA和WB实验验证; 由PhD科学家团队提供全方位技术支持服务。Everest Biotech为众多国际知名抗体公司提供OEM服务。